Previous Article | Next Article ![]()
Infection and Immunity, May 2009, p. 1734-1745, Vol. 77, No. 5
0019-9567/09/$08.00+0 doi:10.1128/IAI.00027-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Departments of Pathology,1 Microbiology and Immunology,2 Center for Biodefense and Emerging Infectious Diseases,3 Sealy Center for Vaccine Development, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas 77555-06094
Received 8 January 2009/ Returned for modification 14 February 2009/ Accepted 28 February 2009
|
|
|---|
|
|
|---|
E. chaffeensis has two morphologically characterized types: a small dense-cored (DC) form characterized by a dense nucleoid and a large replicating form, the reticulate cell (RC), that has uniformly dispersed nucleoid filaments (33). DC ehrlichiae attach and enter the host cell, undergoing rapid transformation to the RC that replicates and matures to the DC form within 3 days (33, 51). The molecular characteristics that distinguish DC from RC forms are not well defined; however, differential expression of two well-characterized immunoreactive tandem repeat (TR) proteins, p120 and p47, on the surface of the DC cells and extracellularly within the ehrlichial endocytic vacuole has been demonstrated (12, 34).
Some of the molecularly characterized major immunoreactive proteins of E. chaffeensis include p47, p120, p200, and variable-length PCR target protein (12, 26, 31, 49). Three of these proteins (p120, p47, and variable-length PCR target protein) contain TRs, are strongly acidic (pI 4 to 5), exhibit high serine/threonine content, contain predicted sites for posttranslational modifications (glycosylation/phosphorylation), and are secreted, suggesting that they are involved in host interactions. In addition, major B-cell epitopes have been identified within the TRs in these proteins (12, 26, 49). Orthologs of E. chaffeensis p47 have been identified, including immunoreactive TR proteins p36 and mucin-like protein (Erum1110) of Ehrlichia canis and Ehrlichia ruminantium, respectively (12).
Entry of E. chaffeensis involves interaction between the pathogen and host that induces cellular signaling events including protein cross-linking by transglutaminase, tyrosine phosphorylation, and phospholipase C-
2 (PLC-
2) activation leading to increased levels of inositol 1,4,5-triphosphate (IP3), and cytosolic free calcium (25). Intracellular survival and proliferation of E. chaffeensis involve modulation of gene transcription, activation, and suppression of tyrosine and mitogen-activated protein kinase (MAPK) activity, downregulation of Toll-like receptors and transcription factors, inhibition of apoptosis, lysosomal fusion, and endosomal maturation, and upregulation of transferrin receptor gene expression in the phagocyte (3, 21-25, 52). Antiehrlichial activity of gamma interferon (IFN-
) is also inhibited by blocking of tyrosine phosphorylation of Janus kinase (Jak) and signal transducer and activator of transcription (Stat) signaling by E. chaffeensis (22). However, the ehrlichial proteins involved in facilitation of entry, inhibition of apoptosis, and suppression and inhibition of cellular defense mechanisms have not been defined.
To further investigate the role of E. chaffeensis TR proteins in pathobiology, the objective of this study was to identify molecular E. chaffeensis p47-host interactions. We hypothesized that p47 is an ehrlichial effector protein that interacts with multiple host cell proteins essential for cellular entry and survival. In this study, we have identified multiple host proteins with distinct molecular functions that interact with p47, suggesting that it plays an important and complex role in reprogramming host cell processes to create a hospitable environment for ehrlichial survival.
|
|
|---|
Antibodies. Rabbit anti-p47 antibody was prepared against keyhole limplet hemocyanin-conjugated 19-mer TR peptide (ASVSEGDAVVNAVSQETPA), and rabbit anti-PCGF5 antibody was prepared against a keyhole limpet hemocyanin-conjugated 19-mer peptide (PKVDEEGDENEDDKDYHRS) by commercial vendors (Biosynthesis, Lewisville, TX, and GenScript, Piscataway, NJ, respectively). Other antibodies used in this study were rabbit anti-human protein tyrosine phosphatase, non-receptor type 2 (PTPN2; Proteintech Group, Chicago, IL), rabbit anti-human FYN (Santa Cruz Biotechnology, Santa Cruz, CA), mouse anti-human FYN (p59 FYN; Sigma Chemical, St. Louis, MO), mouse anti-adenylate cyclase-associated protein 1 (CAP1) (Abnova, Walnut, CA), rabbit anti-green fluorescent protein (GFP), and mouse anti-GAL4 DNA-binding domain (GAL4-BD) tag (Clonetech, Mountain View, CA).
Plasmid construction. To examine E. chaffeensis p47 interactions, a bait plasmid was constructed by fusing full-length p47 with GAL4-BD in pGBKT7 (Clontech, Mountain View, CA). The coding region of p47 was amplified by PCR from E. chaffeensis genomic DNA using a forward primer that included a 5' EcoRI site (5'-GGCGAATTCATGCAGGTTGATGTTGG) and reverse primer with a 5' SalI site (5'-GGCGTCGACCTATTACCAAATTGAGCAGC) (restriction enzyme sites in boldface), and ligated into the complementary sites of pGBKT7 plasmid containing the GAL4-BD. The resulting bait plasmid pGBKT7-p47 was transformed into yeast (Saccharomyces cerevisiae) strain AH109 (Clontech) and selected by growth on minimal synthetically defined medium for yeast (SD) lacking L-tryptophan (SD/–Trp). The expression of bait protein p47 was examined by Western blotting using the lysates from pGBKT7-p47-transformed yeast strain AH109. A strategy similar to that described above for the full-length p47 was used to generate amino (N)-terminal (p471-380) and carboxy (C)-terminal (p47361-842) E. chaffeensis p47 fragments. E. chaffeensis genomic DNA was amplified with a forward primer containing a 5' EcoRI site (5'-GGCGAATTCATGCAGGTTGATGTTGG) and reverse primer with a 5' SalI site (5'-GGCGTCGACGCATTTCCTTCAAGAACTG) for the N-terminal region of p47 and a forward primer containing a 5' EcoRI site (5'-GGCGAATTCCCAGTTCTTGAAGGAAATG) and a reverse primer with a 5' SalI site (5'-GGCGTCGACCTATTACCAAATTGAGCAGC) for the C-terminal region of p47. Each PCR product was cloned into the EcoRI and SalI sites of pGBKT7 containing the GAL4-BD.
p47 expression in yeast. To examine p47 expression in yeast, a single isolated pGBKT7-p47-transformed colony was grown overnight in 5 ml SD/–Trp medium until the optical density at 600 nm (OD600) reached 0.6. The cells were centrifuged at 1,000 x g for 5 min at 4°C, and the cell pellet was resuspended in 100 µl prewarmed cracking buffer (8 M urea, 5% sodium dodecyl sulfate [SDS], 40 mM Tris-HCl [pH 6.8], 0.1 mM EDTA, 0.4 mg/ml bromophenol blue, 1% β-mercaptoethanol, 50 mM phenylmethylsulfonyl fluoride, 6.2 µg/ml pepstatin A, 23.1 µg/ml aprotinin, 1.9 µM leupeptin, 9 mM benzamidine) per 7.5 OD600 units of cells. The cell suspension was transferred to a 1.5-ml microcentrifuge tube containing 80 µl of glass beads (425 to 600 µm; Sigma). Samples were heated at 70°C for 10 min, vortexed vigorously for 1 min, and centrifuged at 14,000 rpm for 5 min at 4°C. Supernatant was boiled for 3 to 5 min, and SDS-polyacrylamide gel electrophoresis and Western immunoblotting were performed as previously described (28). Briefly, yeast extracts were resolved on 4 to 12% Bis-Tris gels and transferred to a nitrocellulose membrane. Immunoblot detection of expressed recombinant p47 (pGBKT7-p47; GAL4-BD fused to p47) protein in yeast was performed with mouse anti-GAL4-BD antibody (1:2,000). Bound primary antibodies were detected with alkaline phosphatase-conjugated anti-mouse immunoglobulin G [IgG(H+L)] secondary antibody (Kirkegaard & Perry Laboratories, Gaithersburg, MD) and visualized after incubation with BCIP/NBT (5-bromo-4-chloro-3-indolylphosphate-nitroblue tetrazolium) substrate.
Yeast two-hybrid assays.
Yeast two-hybrid screening was performed using Matchmaker Two-Hybrid System 3 according to the manufacturer's protocol (Clontech). The pretransformed human bone marrow Matchmaker cDNA library was constructed in pGADT7, fused with GAL4-activation domain (GAL4-AD), and then transformed in S. cerevisiae strain Y187 (Clontech) and selected with SD/–Leu. Library clones expressing interacting prey proteins were screened by yeast mating. Positive clones were selected on SD quadruple-dropout (QDO) medium (SD/–Ade/–His/–Leu/–Trp) and confirmed on QDO medium supplemented with 5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-
-Gal) (Clontech). QDO-positive clones were then isolated, and the prey plasmids were sequenced in the UTMB Protein Chemistry Laboratory.
Confirmation of positive interactions and prey plasmid rescue.
To confirm positive interactions, the library plasmids responsible for activation of reporters were rescued and reisolated two or three times on SD double-dropout (DDO) medium (SD/–Leu/–Trp) containing X-
-Gal. The segregated library plasmid was rescued from the positive clones grown on QDO using the Yeastmaker yeast plasmid isolation kit (Clontech). The prey plasmid was isolated from transformed Escherichia coli cells selected on LB plus 100 µg/ml ampicillin. To distinguish positive from false-positive interactions, competent S. cerevisiae strain AH109 cells were cotransformed with the bait plasmid (pGBKT7-p47) and the prey plasmid. In another set of experiments, competent AH109 cells were cotransformed with empty bait plasmid (pGBKT7-empty) and the prey plasmid. The positive interactions were confirmed by selection on DDO and QDO media supplemented with X-
-Gal after 3 to 5 days of incubation. The competent AH109 cells were cotransformed with empty bait (pGBKT7-empty) and the prey plasmid and were selected on DDO and QDO media.
Transfection and immunoprecipitation.
Two mammalian expression vectors, pAcGFP1-C and pProLabel-C, were used for generation of N-terminal-tagged AcGFP1-bait and ProLabel prey fusion proteins. The mammalian expression vector pAcGFP1 encodes GFP, while the pProLabel mammalian expression vector encodes the ProLabel tag (
6 kDa; β-galactosidase). The bait p47, Nterm p47, or Cterm p47 was cloned in-frame downstream of the AcGFP1 coding sequence (at SalI/HindIII) and expressed as a C-terminal AcGFP1 fusion protein. The prey gene was cloned into SalI/BamHI-linearized pProLabel vector in-frame downstream of the ProLabel tag and expressed as a C-terminal ProLabel tag fusion protein. Top10 E. coli (Invitrogen, Carlsbad, CA) or Fusion blue (Clontech) chemically competent cells were transformed according to the manufacturer's protocol, and positive transformants were screened by PCR, restriction digestion, and DNA sequencing. AcGFP1-p47, AcGFP1-Nterm p47, or AcGFP1-Cterm p47 and ProLabel-tagged prey fusion proteins were coexpressed in mammalian cells (HeLa cells), and interacting proteins were immunoprecipitated with the Matchmaker chemiluminescent coimmunoprecipitation (Co-IP) kit according to the manufacturer's protocol (Clontech). Briefly, HeLa cells were contransfected using Lipofectamine (Invitrogen) with pAcGFP1-p47, pAcGFP1-Nterm p47, or pAcGFP1-Cterm p47 and pProLabel-tagged prey fusion constructs, and posttransfection expression of GFP was confirmed after 48 h. The cells were washed twice with 1x phosphate-buffered saline (PBS), and the cell pellet was collected and resuspended in cell lysis buffer (2 x 106 cells/ml) including phenylmethylsulfonyl fluoride and a cocktail of protease inhibitors (Pierce, Rockford, IL) and incubated in ice for 30 min. The cell lysate was centrifuged at 10,000 x g for 20 min at 4°C, the supernatant was collected, and the protein concentration was determined by the bicinchoninic acid method (Pierce). Anti-AcGFP1 polyclonal antibody was added to 500 µg/ml of lysate and incubated for 2 h at 4°C. After the antibody incubation, lysate was added to washed protein A/G agarose beads at a 1:20 volume of 50% bead slurry and the mixture was incubated for overnight at 4°C. Beads were collected by centrifugation (5,000 x g for 10 s), washed 5x with wash buffer 1, and then 4x with wash buffer 2. For ProLabel detection of protein-protein interaction, each sample of beads was resuspended in 80 µl of lysis/complementation buffer, and the entire content of beads and buffer was transferred to a well in a 96-well assay plate (Costar, Corning, NY). To each well, 30 µl of substrate mix was added and ProLabel activity measured using the Veritas microplate luminometer (Turner Biosystems, Sunnyvale, CA) at 0-, 10-, 15-, 20-, 25-, 30-, 45-, 60-, 90-, and 120-min intervals.
Confocal microscopy. Untransfected and transfected (pAcGFP1-p47 and pAcGFP1-empty) HeLa cells collected 2 days posttransfection were washed twice with 1x PBS and fixed in 3.7% paraformaldehyde at room temperature for 15 min. Cells were permeabilized and blocked with a mixture of 0.1% Triton X-100 and 1% bovine serum albumin (Sigma) in 1x PBS for 1 h at room temperature. Uninfected and E. chaffeensis-infected THP-1 cells (2 to 3 days postinfection) were cytocentrifuged onto glass slides, fixed in 3.7% paraformaldehyde for 20 min, and permeabilized and blocked with a mixture of 1% Triton X-100 and 5% bovine serum albumin in 1x PBS for 1 h at room temperature. Cells were stained with anti-PCGF5, anti-FYN, anti-PTPN2 (1:50), or anti-CAP1 (1:100) antibodies for 1 h at room temperature. Slides were washed and incubated with Alexa Fluor 568 goat anti-rabbit or goat anti-mouse IgG(H+L) secondary antibodies (1:100) (Molecular Probes, Eugene, OR) for 30 min. Slides were then washed and mounted with ProLong antifade (Invitrogen), and fluorescent images were obtained at the Optical Imaging Laboratory at UTMB using a Zeiss LSM 510 META laser-scanning confocal microscope (Germany). The confocal images were further analyzed by use of fluorescence intensity profiles. A fluorescence intensity profile represents the pixel values in a digitized section along a user-defined area, displayed in a diagram. The electrical signal from the detector was digitized to a numerical value between 0 and 250 arbitrary units.
Statistics. Statistical difference between control and experimental groups were assessed with the two-tailed Student's t test. Significance is indicated by a P value of <0.05.
|
|
|---|
![]() View larger version (33K): [in a new window] |
FIG. 1. Schematic representation of E. chaffeensis p47 and regions of homology with renin receptor and DNA polymerase III subunits. (A) The amino (N)-terminal region is shaded (white bar) and precedes the seven 19-mer (ASVSEGDAVVNAVSQETPA) TRs (47% of the total protein sequence) region (gray bars). (B) The surface accessibility curve (13) predicts that each of the seven 19-mer TRs (numbered 1 to 7 over the curve) is surface exposed. (C) The C-terminal region of p47 contains six renin receptor-like motifs (14). (D) The DNA polymerase III subunit gamma and tau conserved domain (multi-domain PRK05648) was identified from NCBI Conserved Domain Database (CDD) (1). The computationally detected multi-domains are present in the same region of C-terminal region of p47 that contains the seven 19-mer TRs.
|
-Gal. Colonies were not observed after 3 to 5 days of incubation, confirming a lack of autoactivation by p47 (Fig. 2A). To examine toxicity, AH109 cells transformed with pGBKT7 (empty) and pGBKT7-p47 were grown in both solid and liquid media. No significant differences in yeast growth in solid or liquid medium containing bait and empty plasmids was observed, demonstrating that the bait was nontoxic to yeast. E. chaffeensis p47/Gal4-BD fusion protein expression in yeast was confirmed by transforming yeast AH109 with pGBKT7-p47, extracting yeast protein (urea/SDS method), and by Western immunoblotting with an anti-DNA-BD monoclonal antibody (Fig. 2B).
![]() View larger version (41K): [in a new window] |
FIG. 2. Yeast two-hybrid human bone marrow library clones that interacted with E. chaffeensis p47. (A) E. chaffeensis p47 was screened for autoactivation in S. cerevisiae strain AH109 containing pGBKT7-p47 and a positive control (AH109/Y187 diploid with pGBKT7-p53 [murine p53] and pGADT7-T [simian virus 40 large T antigen] generated by mating the S. cerevisiae strains AH109 [pGBKT7-53] and Y187 [pGADT7-T]) and selected with TDO medium. (B) Expression of p47/GAL4-BD (arrow; p47 size = 47 kDa + 21-kDa GAL4-BD tag [68 kDa total]) was determined by immunoblotting of yeast cell extracts transformed with pGBKT7-p47 (lane 1) or pGBKT7-empty (lane 2) using anti-GAL4-BD antibody. (C) To identify possible interacting clones, diploids were selected on QDO medium. A positive interaction was detected by using a diploid containing pGBKT7-p53 and pGADT7-T (plate on the left side of panel C), and the diploid containing pGBKT7-empty and pGADT7-T was used as a negative control (plate on right side of panel C). (D) S. cerevisiae strain AH109 expressing pGBKT7-p47 was mated with S. cerevisiae strain Y187 expressing PCGF5, FYN, PTPN2, and CAP1 (plates on the left side of panel D). S. cerevisiae strain AH109 expressing pGBKT7-empty was mated with S. cerevisiae strain Y187 expressing PCGF5, FYN, PTPN2, and CAP1 (plates on the right side of panel D). Diploids were selected as described for panel C.
|
-Gal identifying potential positive clones that exhibited bait and prey protein-protein interactions. One hundred four colonies were selected for yeast colony PCR followed by DNA sequencing to eliminate the duplicate clones and identify host-interacting partners. The 15 most abundant clones identified in order of frequency were PCGF5, Ig lambda-like polypeptide 1 (IGLL1), Stat6, CYP4F3, IgM light chain, PTPN2, LMAN1, Stat5a, RAI1, UBB, L30, PTPN1, LGALS3, KARS, and ribosomal protein L4. To identify the true interactions and eliminate the false positives, cotransformation assays were performed in yeast with 33 candidate prey plasmids, including the most abundant clones and some clones that were less abundant. Interactions were confirmed with 7 of 33 prey proteins: Polycomb group ring finger 5 (PCGF5), Src protein-tyrosine kinase FYN (FYN), PTPN2, CAP1, IGLL1, NW_001838484.1 and NT_005612.15 (Fig. 2C and D). To confirm the yeast two-hybrid results, we independently examined the interaction of p47 with these prey proteins in mammalian cells by Co-IP and confirmed a direct interaction between p47 and five prey proteins (Table 1). The relative strengths of the interaction between p47 and PCGF5, FYN, PTPN2, CAP1, and IGLL1 were 12, 12, 5, 3, and 3 times higher than those of the respective controls (in the absence of p47; AcGFP1-empty) (Fig. 3A). These results identified p47 as an interacting partner since in the absence of p47 the relative physical interaction values were very low and comparable to each other among the prey proteins (23 to 38 relative light units [RLU]). The full-length p47 interacted with each prey protein specifically and differentially, which is demonstrated by very high relative physical interaction values (468 RLU for PCGF5 to 74 RLU for IGLL1) (Fig. 3A). To confirm the specificity of the protein-protein interaction, the pAcGFP1-p47 and pProLabel-empty vectors were cotransfected to HeLa cells and Co-IP was performed. The relative low RLU (30) value indicated that there was no protein-protein interaction between AcGFP-p47 and pProLabel-empty and demonstrated that the presence of specific prey protein was required for p47-prey protein interaction (Fig. 3A). These data confirmed the yeast two-hybrid results and also indicated that p47 interacted most strongly with PCGF5 and FYN, followed by PTPN2, CAP1, and IGLL1. The top four candidates (PCGF5, FYN, PTPN2, and CAP1) were examined further for interactions with p47. |
View this table: [in a new window] |
TABLE 1. Summary of human proteins that interact with E. chaffeensis p47 as determined by yeast two-hybrid and Co-IP assays
|
![]() View larger version (17K): [in a new window] |
FIG. 3. E. chaffeensis p47 interaction with multiple human proteins with distinct functional properties. AcGFP (control, without insert) and AcGFP-p47 were coexpressed with ProLabel (control, without insert) and ProLabel-PCGF5, -FYN, -PTPN2, -CAP1, -IGLL1 as fusion proteins in HeLa cells. ProLabel activity was measured at different time intervals after addition of substrate. The ProLabel tag associated with AcGFP-p47 fusion protein and enzyme acceptor combine to form an active enzyme that cleaves the chemiluminescent substrate. The resulting signal is detected with a luminometer as RLU. The ProLabel tag is the limiting constituent and is governed by its interaction with AcGFP-p47 fusion protein. (A) Relative strength and interaction of AcGFP and AcGFP-p47 with ProLabel-PCGF5, -FYN, -PTPN2, -CAP1, and -IGLL1. The results are from three independent experiments. The values are means ± standard deviations shown as RLU. An asterisk indicates that the RLU of AcGFP-p47+PCGF5, AcGFP-p47+FYN, AcGFP-p47+PTPN2, AcGFP-p47+CAP1, AcGFP-p47+IGLL1 were significantly higher than those of AcGFP+PCGF5, AcGFP+FYN, AcGFP+PTPN2, AcGFP+CAP1, and AcGFP+IGLL1 (P < 0.005). (B) Relative strength and interaction of AcGFP, AcGFP-Nterm p47, and AcGFP-Cterm p47 with PL-PCGF5, -FYN, -PTPN2, and -CAP1. The results are from three independent experiments. The values are means ± standard deviations shown as RLU. The RLU of AcGFP-Ctermp47+PCGF5 was significantly higher than those of AcGFP+PCGF5 (*, P < 0.005). AcGFP, pAcGFP1 without insert; AcGFP-p47, pAcGFP1-p47; PL-C, ProLabel without insert; PCGF5, FYN, PTPN2, CAP1, and IGLL1, PL-PCGF5, PL-FYN, PL-PTPN2, PL-CAP1, and PL-IGLL1, respectively; Nterm p47, amino-terminal p47; Cterm p47, carboxy-terminal p47.
|
Recombinant E. chaffeensis p47 (pAcGFP1-p47) colocalizes with FYN, PTPN2, and CAP1. Interactions between p47 and three interacting proteins (FYN, PTPN2, and CAP1) were examined in transfected mammalian cells (HeLa). Immunofluorescent confocal microscopy revealed that recombinant p47 colocalized with FYN, PTPN2, and CAP1 (Fig. 4A to I). Recombinant E. chaffeensis p47 and host cell protein-tyrosine kinase FYN exhibited primarily diffuse cytoplasmic and perinuclear colocalization in the cell (Fig. 4A to C), although a few punctate colocalized spots were observed associated with plasma membrane and cytoplasm (Fig. 4A to C, also see insets for details). In the case of PTPN2, both cytoplasmic and nuclear colocalization of recombinant p47 and PTPN2 was detected in a small punctulated pattern (Fig. 4D to F). Although most of PTPN2-p47 interaction was associated with cytoplasm (Fig. 4E), some was localized in the nucleus of the cell (Fig. 4F). A diffused colocalization of p47 and CAP1 was observed exclusively in the cytoplasm (Fig. 4G to I). The confocal intensity profile (a profile shown as a red line in the confocal image in Fig. 5) collected across the transfected HeLa cells stained with FYN, PTPN2, and CAP1 indicated a similar distribution pattern of recombinant p47 (green) and FYN, PTPN2, and CAP1 (red) (Fig. 5A to C).
![]() View larger version (60K): [in a new window] |
FIG. 4. Colocalization of FYN, PTPN2, and CAP1 with AcGFP-p47 in HeLa cells. pAcGFP-p47-transfected HeLa cells (2 days posttransfection) were labeled and observed by confocal laser-scanning microscopy. The AcGFP-p47 (green) (A, D, and G) and anti-FYN (red; B), anti-PTPN2 (red; E), and anti-CAP1 (red; H) signals were merged, respectively (C, F, and I). FYN, PTPN2, and CAP1 colocalize with p47 (C, F, and I). The arrow indicates the punctulated colocalization of p47 and FYN. In the insets (A, B, and C), the arrow indicates an area highlighted to show the membrane colocalization of p47 and FYN. Small punctulated colocalization of p47 and PTPN2 is observed mostly in the cytoplasm of HeLa cells (F). Bar, 10 µm.
|
![]() View larger version (19K): [in a new window] |
FIG. 5. Fluorescent confocal microscopy and intensity profiles of HeLa cells expressing AcGFP-p47 (p47-green) fixed and stained with DAPI (blue) and anti-FYN, -PTPN2, or -CAP1 antibodies (red) showing colocalization of p47 with FYN (A), PTPN2 (B), and CAP1 (C). The red line in the confocal image indicates the area selected for fluorescence intensity profile analysis and is displayed in graph form (below). The x axis shows distance (µm), and the y axis shows intensity (0 to 250 arbitrary units).
|
![]() View larger version (56K): [in a new window] |
FIG. 6. Colocalization of E. chaffeensis p47 with PCGF5, FYN, PTPN2, and CAP1 in E. chaffeensis-infected THP-1 cells. THP-1 cells were infected with E. chaffeensis and 3 days postinfection were dually labeled and examined by confocal microscopy. The panels on the right are merged images. PCGF5, FYN, PTPN2, and CAP1 colocalize with E. chaffeensis p47-labeled morulae (yellow, right panels). Differential expression of E. chaffeensis p47 by a subset of ehrlichiae compared to Dsb (constitutively expressed by E. chaffeensis) is revealed by double-immunofluorescent labeling of E. chaffeensis-infected THP-1 cells with anti-E. chaffeensis Dsb (inset in Fig. 6A, green) and anti-p47 (inset in Fig. 6B, red) sera; the merged image (inset in Fig. 6C) demonstrates the singly (green, marked with arrowhead) and dually labeled (yellow, marked with arrow) E. chaffeensis. In the inset (bottom, right panel), a normal uninfected THP-1 cell reveals that CAP1 is mainly associated with plasma membrane, while in the E. chaffeensis-infected THP-1 cell, CAP1 is distributed in cytoplasm and associated with E. chaffeensis-containing morulae. Bar, 10 µm.
|
![]() View larger version (21K): [in a new window] |
FIG. 7. Fluorescent confocal microscopy and intensity profiles of E. chaffensis-infected THP-1 cells fixed and stained with DAPI (blue), anti-p47 (green) and anti-FYN, -PTPN2, or -CAP1 antibodies (red) showing colocalization of p47 with FYN (A), PTPN2 (B), and CAP1 (C). The red line in the confocal image indicates the area selected for fluorescence intensity profile analysis and is displayed in graph form (below). The x axis shows distance (µm), and the y axis shows the intensity (0 to 250 arbitrary units). FYN (red) and PTPN2 (red) colocalize and associate with p47 (green), as revealed in diagrams A and B, respectively. In panel C, the profile along the E. chaffeensis-infected THP-1 cells displays that CAP1 (red) surrounds the E. chaffeensis-containing morulae stained with p47 (green) and also with DAPI (blue).
|
|
|
|---|
![]() View larger version (47K): [in a new window] |
FIG. 8. Proposed model of the role of p47 in E. chaffeensis infection and survival in monocytes based on this study and previous reports (22-24, 51, 52). Binding of E. chaffeensis to its receptor directly or indirectly activates FYN. Activated FYN tyrosine kinase phosphorylates and activates PLC- , which hydrolyzes membrane phospholipid PIP2 (phosphatidylinositol biphosphate), resulting in increased level of IP3 and release of Ca2+ from intracellular stores, and Ca2+ influx. FYN may regulate the function of IP3 receptor by phosphorylation and promoting release of Ca2+ from the endoplasmic reticulum. FYN also phosphorylates caveolin-1 involved in ehrlichial entry. p47-PTPN2 interaction modulates cytokine signaling events by exerting negative feedback on the Jak/Stat pathway by dephosphorylation of Jaks and Stats involved in intravacuolar maintenance and survival of E. chaffeensis. p47-PCGF5 interaction modulates gene transcription associated with cell signaling and remodeling of cytoskeleton, facilitating and supporting intracellular survival of E. chaffeensis. CAP1 promotes rapid actin dynamics in conjunction with ADF/cofilin and is required for cell morphology, migration, and endocytosis. Mitochondrial shuttling of CAP1 promotes actin- and cofilin-dependent apoptosis, which may play important role in release of DC ehrlichiae from the monocyte.
|
In the yeast two-hybrid experiments, PCGF5 protein was the most frequently identified interacting partner and exhibited the strongest protein-protein interaction with p47. This was consistent with the immunofluorescence microscopy results that indicated a strong PCGF5 immunofluorescence and colocalization with p47 expressed by DC ehlichiae in dually stained infected cells. PCGF5 has not been extensively studied, but it appears to be involved in DNA-dependent regulation of transcription, metal ion binding, and protein-protein interactions. PCGF5 has a specialized Zn finger domain consisting of 40 to 60 residues that binds two atoms of zinc and is defined by the "cross-brace" motif involved in protein-protein interactions (6, 17, 37). PCGF5 is related to the Polycomb group proteins (transcriptional repressors) Bmi-1/PCGF4 and Mel-18/PCGF2 (36, 39), which play an important role in the regulation of Hox gene expression, X-chromosome inactivation, tumorigenesis, and self-renewal; maintenance of pleuripotency of stem cells; and stimulation of E3 ubiquitin ligase activity (10, 30, 45). Bmi-1 and Mel-18 regulate gene expression associated with extracellular matrix remodeling, cell adhesion, and integrin-mediated signaling and affect the expression of the constituent members of vascular endothelial growth factor (VEGF), and AKT signaling pathway (46). Thus, p47-expressing DC ehrlichiae may recruit PCGF5 in an effort to modulate host cell gene expression to favor survival. Altered gene expression in E. chaffeensis-infected cells has been reported, but the mechanisms involved are unknown (52). A Co-IP experiment using C- and N-terminal deletion mutants of p47 identified the C-terminal, TR-containing region of E. chaffeensis p47 as the primary interaction domain with PCGF5. However, the interaction between PCGF5 and C-terminal region of p47 was weaker than the interaction between PCGF5 and full-length p47, demonstrating the contribution of the p47 N-terminal region in the interaction. Furthermore, none of the full-p47-interacting partners, including PCGF5, FYN, PTPN2, and CAP1, interacted with the N-terminal region of p47 devoid of TR, further implicating the importance of the both C- and N-terminal domains in these protein-protein interactions.
One of the first events for entry and infection is the recruitment of tyrosine-phosphorylated protein and PLC-
2 in the early nascent morulae containing the DC ehrlichiae (24, 51). Tyrosine-phosphorylated protein and PLC-
2 colocalize with caveolin-1 in caveolae containing E. chaffeensis (2, 24). Tyrosine kinases are known to be involved in ehrlichial entry; however, the specific kinases involved have not been determined. A strong p47-FYN interaction, similar to p47-PCGF5, was discovered by a yeast two-hybrid assay and was reflected by a robust immunofluorescence and colocalization of p47 and FYN in dually stained infected cells. FYN is a cytosol, endosome, and membrane-associated, non-receptor protein tyrosine kinase and a member of the Src family that is enriched in caveoalae (2). The association of p47 with FYN and the intracellular DC form of E. chaffeensis suggests that it may be recruited by p47 to facilitate the entry process. FYN specifically phosphorylates caveolin-1 and is required for coxsackievirus internalization and infection via caveolin-associated vesicles to polarized epithelial cells (11). FYN was not observed associated with E. chaffeensis RCs, demonstrating a selective association with DC ehrlichiae that express p47.
Another p47-interacting protein, PTPN2, is a member of the protein tyrosine phosphatase (PTP) family also known as T-cell PTP (TC-PTP) that catalyzes the dephosphorylation of phosphotyrosine peptides and regulates phosphotyrosine levels in signal transduction pathways. PTPs are known to regulate a variety of cellular processes, including cell growth, differentiation, mitotic cycle, and oncogenic transformation (42). Multiple substrates of PTPN2 included colony-stimulating factor CSF-1R, epidermal growth factor receptor, platelet-derived growth factor receptor, IR, p52Shc, Jak1, Jak3, Stat1, Stat3, Stat5a/b, and Stat6 (42). The in vivo and in vitro analyses indicate that PTPN2 could control cytokine signaling events by their negative action on the Jak/Stat pathway (41, 42). The loss of PTPN2 results in Stat5 hyperactivation, increased production of IFN-
, tumor necrosis factor alpha (7), interleukin-12, and inducible nitric oxide synthase; increased tyrosine phosphorylation and recruitment of a Grb2/Gab2/Shp2 complex to the CSF-1 receptor; and enhanced activation of ERK and may affect transcription factor PU.1 signaling (8, 19, 40, 41, 48). The Jak/Stat pathway is inhibited by E. chaffeensis (22), and our results support the possibility that p47 may be involved in the inhibition of IFN-
-induced tyrosine phosphorylation of Stat1, Jak1, and Jak2 by interacting with PTPN2.
The localization of CAP1 with the DC morulae was observed adjacent to the morula boundaries (membrane), and CAP1 was not observed inside the morula space as was observed with PCGF5, FYN, and PTPN2. p47 is secreted and has been demonstrated on the morula membrane containing the DC ehrlichiae (12); thus, the interaction between p47 and CAP1 appears to occur at the morula membrane interface. The distribution pattern of CAP1 was remarkably different in E. chaffeensis-infected cells from that in normal cells, where it is primarily associated with the plasma membrane, indicating that the distribution of this protein is altered as a result of E. chaffeensis infection. CAPs were originally identified in yeast as a component of the adenylyl cyclase complex, and yeast cells deficient in CAPs are defective in cytoskeleton organization. Although CAPs do not regulate cyclic AMP in animal cells, their role in regulation of actin remodeling in response to cellular signals is widely conserved. CAP1 is highly conserved monomeric actin binding protein that contains actin (C terminal), adenylyl cyclase, and cofilin (N terminal), and Src homology 3 (SH3) and profilin (central region) binding domains (5, 16, 29). Genetic studies in yeast have implicated CAP1 in vesicle trafficking and endocytosis (18, 35). In mammalian cells, CAP1 is associated with an SH3 domain-dependent mAbp1/dynamin complex involved in receptor-mediated endocytosis (20).
Ehrlichia and Anaplasma spp. are known to inhibit apoptosis, but the molecular mechanisms are not well understood. Ehrlichiae, like chlamydiae, inhibit apoptosis early in infection, but while chlamydiae induce cell death at the end of the infection cycle, ehrlichial exit mechanisms remain undefined (15, 43, 47). Interestingly, CAP1 has also been implicated in promoting apoptosis by functioning as an actin shuttle to mitochondria. Similar to cofilin, BAD, and BAX, CAP1 rapidly translocates to mitochondria independent of caspase activation, where it promotes apoptosis (44, 50). Associations between ehrlichial morula and mitochondria have been consistently observed (33, 51). Thus, p47 and CAP1 interaction may serve a dual function by facilitating endocytosis and vesicle trafficking and promoting apoptosis in the late stages of infection.
Ehrlichiae must interact with the host cell to reprogram host cell defense mechanisms. E. chaffeensis p47 interacts with and appears to facilitate the recruitment of PCGF5, FYN, PTPN2, and CAP1 to morula containing DC E. chaffeensis. This newly identified interaction between a DC ehrlichia-expressed protein, p47, and the multiple host proteins involved in regulation of gene transcription, vesicle trafficking, and cell signaling pathways suggests that identification of additional interacting host cell ligands of other DC cell-expressed proteins will facilitate studies to elucidate the function of this unique class of ehrlichial proteins. Further research is needed to understand the mechanisms which underlie these host-pathogen molecular interactions and the importance of these interactions in E. chaffeensis pathobiology.
We are grateful to Rhykka L. Connelly and Thomas Albrecht in the Infectious Disease and Toxicology Optical Imaging Core at UTMB for assistance with confocal microscopy. We also thank David H. Walker and Xue-jie Yu for reviewing the manuscript and providing helpful suggestions.
Published ahead of print on 9 March 2009. ![]()
|
|
|---|
. Blood 109:4220-4228.
2 and increase in cytosolic free calcium are required by Ehrlichia chaffeensis for internalization and growth in THP-1 cells. Infect. Immun. 70:889-898.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»